Quantcast
Last updated on April 19, 2014 at 17:21 EDT

Latest Atypical antipsychotics Stories

2014-04-06 23:01:17

Study Released as Risperdal Lawsuits Alleging Use of Antipsychotic Drug Caused Gynecomastia (Male Breast Growth) in Men and Boys Continue to Move Forward in Pennsylvania Columbus, OH (PRWEB) April 06, 2014 Wright & Schulte LLC, an experienced law firm representing clients in Risperdal lawsuits, notes that a new study has linked use of the atypical antipsychotic medication to gynecomastia, or male breast growth. The release of the study, which was presented in March at the 2014 Annual...

2014-04-02 23:01:07

The Firm continues to investigate Risperdal lawsuits that allege the atypical antipsychotic drug caused male breast development, or gynecomastia. New York, New York (PRWEB) April 02, 2014 The nationwide law firm of Bernstein Liebhard LLP is actively filing Risperdal lawsuits (http://www.risperdallawsuitcenter.com/) on behalf of individuals who allegedly suffered gynecomastia, or male breast growth, due to their use of the atypical antipsychotic. On March 26, 2014, the Firm filed a claim...

2014-03-20 08:29:49

Independent Data Monitoring Committee Recommends Halting Trial and Unblinding Data Based on Treatment Efficacy TITUSVILLE, N.J., March 20, 2014 /PRNewswire/ -- Janssen Research & Development, LLC announced today that following an Independent Data Monitoring Committee (IDMC) recommendation based on positive efficacy, it has halted early a Phase 3 clinical study of paliperidone palmitate 3-month formulation, an investigational treatment for symptoms of schizophrenia in adults. "We are...

2014-03-03 08:31:55

ADASUVE is the first and only orally inhaled medicine for the acute treatment of agitation associated with schizophrenia or bipolar I disorder in adults MOUNTAIN VIEW, Calif., March 3, 2014 /PRNewswire/ -- Alexza Pharmaceuticals, Inc. (Nasdaq: ALXA) today announced the U.S. commercial launch of ADASUVE(®) (loxapine) inhalation powder 10mg by its commercial partner, Teva Pharmaceutical Industries Ltd., (NYSE: TEVA). ADASUVE is the first and only orally inhaled medicine for the acute...

2014-02-11 16:25:38

First liquid formulation clozapine for treatment-resistant schizophrenia DUBLIN, Feb. 11, 2014 /PRNewswire/ -- Jazz Pharmaceuticals plc (Nasdaq: JAZZ) today announced U.S. commercial availability of Versacloz(TM) (clozapine, USP) oral suspension, the first and only oral suspension clozapine for severely ill treatment-resistant schizophrenia patients or those at risk of recurrent suicidal behavior with schizophrenia or schizoaffective disorder. "We are pleased to offer patients with...

2014-01-21 23:29:42

The DrugRisk Center is the Web’s largest source for information on prescription drug warnings, side effects and legal news. Visit http://www.DrugRisk.com Philadephia, PA (PRWEB) January 21, 2014 The prescription drug safety advocates at DrugRisk.com have added new information to the site for patients and families of those who have taken the antipsychotic drug Risperdal. Court records show lawsuits alleging the drug caused abnormal breast growth have now spread to federal court*....

2014-01-16 23:00:27

http://www.DrugNews.net is the web’s premier source for prescription drug warnings, research, side effects and legal news. Visit the DrugNews Center today. Philadelphia, PA (PRWEB) January 16, 2014 The medication safety advocates at DrugNews.net are announcing updated information for patients and parents of those who have taken the antipsychotic drug Risperdal. Court documents show patients alleging the drug caused abnormal breast growth have asked a judge to unseal data from Risperdal...

2014-01-09 23:25:48

The DrugRisk Center is the Web’s largest source for information on prescription drug warnings, side effects and legal news. Visit http://www.DrugRisk.com Philadelphia, PA (PRWEB) January 09, 2014 The drug safety resource DrugRisk.com has added new information to the site for patients and families of those who have taken the antipsychotic drug Risperdal. According to court documents, plaintiffs alleging the drug caused abnormal breast growth have asked a judge to unseal data from...

2013-12-20 23:24:44

http://www.DrugNews.net is the web’s premier source for prescription drug warnings, research, side effects and legal news. Visit the DrugNews Center today. New York, NY (PRWEB) December 20, 2013 The medication safety advocates at DrugNews.net are announcing updated information for patients and parents of those who have taken the antipsychotic drug Risperdal. Patients alleging the drug caused abnormal breast growth have asked a judge to unseal data from Risperdal clinical studies,...

2013-12-04 23:31:22

http://www.DrugNews.net is the web’s premier source for prescription drug warnings, research, side effects and legal news. Visit the DrugNews Center today. New York, NY (PRWEB) December 04, 2013 The medication safety advocates at DrugNews.net are announcing a new resource center for parents of children who have taken the antipsychotic drug Risperdal. The site will contain the latest research and safety warnings as well as updated legal news from lawsuits alleging side effects*. DrugNews...